p201.html
P201 Rituximab as rescue therapy in interstitial lung disease refractory to conventional immunosuppression
Wed, 22 Feb 2023 18:03:00 GMT
Background Rituximab, a B cell-depleting monoclonal antibody, may offer an effective rescue therapy in a subgroup of patients with severe interstitial lung disease (ILD), progressing despite ...